ACE
Financiado
ANNULUS CLOSURE EXPANDABLE DEVICE BASED ON SHAPE MEMORY MATERIALS AND MEDICAL TE...
ANNULUS CLOSURE EXPANDABLE DEVICE BASED ON SHAPE MEMORY MATERIALS AND MEDICAL TEXTILES SCALE UP TO PRODUCTION TESTING AND DEMONSTRATION.
The objective of the ACE project is to broaden NEOS’ product portfolio by launching its first Spinal Product, an Annulus Closure Device in 2018. Sales from this product will more than triple NEOS’ turnover between 2018 and 2022. I...
The objective of the ACE project is to broaden NEOS’ product portfolio by launching its first Spinal Product, an Annulus Closure Device in 2018. Sales from this product will more than triple NEOS’ turnover between 2018 and 2022. It will also position NEOS in a very strategic segment of the Spinal Implants Market: Non-Fusion Spinal Implants (900-1400 M€, CAGR 10-18%), consolidating its visibility as a manufacturer of innovative implants.
The ACE provides a permanent solution to an unmet clinical need: disc hernia management. The ACE solves the challenge by providing a barrier to re-herniation which is expandable, is securely fixed to the vertebra, has minimum impact on the current surgery procedure, and respects natural spine movements. This is done by combining expertise in implant design, textile technology, and advanced manufacturing techniques, and was developed by a European consortium in a Eurostars-funded project.
The ACE is currently at TRL6, and is ready for testing in its operational environment. The European patent of the invention is in conversations with the examiner, approval foreseen in 2015. Freedom to Operate had been verified. The ACE has been validated with clinicians and commercial partners and the ACE Business Plan has been approved by NEOS’ Board of Directors.
The ACE will address a Blue Ocean type market with a dynamic IP and start-up landscape, with only one commercially active player at the moment.
The ACE will add value to Patients, Surgeons and Payers by offering a cost-effective, permanent solution to low back pain. NEOS will be the first European company to launch an Annulus Closure Device, which will address many European challenges: the socio-economic impact of low back pain (Health Costs, sick leaves, productivity loss), European industrial leadership in the high added-value Medical Devices sector, and bridging the gap between research and the market.
The ACE is the cornerstone of NEOS’ Strategic Plan to accelerate its growth.
ver más
Duración del proyecto: 38 meses
Fecha Inicio: 2015-07-20
Fecha Fin: 2018-09-30
Fecha Fin: 2018-09-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-09-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
NEOS SURGERY
Diseno, desarrollo, produccion y comercializacion de productos en el campo de la biomedicina y la cirugia
Perfil tecnológico
TRL
4-5
251K
Perfil tecnológico
TRL
4-5
251K